Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine effects on neural circuitry in alcoholism vulnerability
NCT01585168Phase 2Completed
- Sponsor
- Yale University
- Start
- Dec 2011
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in alcohol use disorder (AUD), sponsored by Yale University. Started Dec 2011; status: completed.
02
Drugs
memantine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01585168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585168.